Monsch, Andreas U.

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

Frisoni, G. B., Boccardi, M., Barkhof, F., Blennow, K., Cappa, S., Chiotis, K., Démonet, J.-F., Garibotto, V., Giannakopoulos, P., Gietl, A., et al. (2017) · The Lancet Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 626

DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer’s disease

Douaud, G., Jbabdi, S., Behrens, T. E. J., Menke, R. A., Gass, A., Monsch, A. U., Rao, A., Whitcher, B., Kindlmann, G., Matthews, P. M., et al. (2011) · NeuroImage

Advanced Neuroimaging Techniques and ApplicationsDementia and Cognitive Impairment Research

Cited by 514

A common brain network links development, aging, and vulnerability to disease

Douaud, G., Groves, A. R., Tamnes, C. K., Westlye, L. T., Duff, E. P., Engvig, A., Walhovd, K. B., James, A., Gass, A., Monsch, A. U., et al. (2014) · Proceedings of the National Academy of Sciences

Functional Brain Connectivity StudiesDementia and Cognitive Impairment Research

Cited by 317

Evaluation of smartphone‐based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial

Lipsmeier, F., Taylor, K. I., Kilchenmann, T., Wolf, D., Scotland, A., Schjodt‐Eriksen, J., Cheng, W., Fernandez‐Garcia, I., Siebourg‐Polster, J., Jin, L., et al. (2018) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsBalance, Gait, and Falls Prevention

Cited by 266

Brain microstructure reveals early abnormalities more than two years prior to clinical progression from mild cognitive impairment to Alzheimer's disease

Douaud, G., Menke, R. A. L., Gass, A., Monsch, A. U., Rao, A., Whitcher, B., Zamboni, G., Matthews, P. M., Sollberger, M., & Smith, S. (2013) · The Journal of Neuroscience

Dementia and Cognitive Impairment ResearchAdvanced Neuroimaging Techniques and Applications

Cited by 180

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer’s disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.

Burns, D. K., Alexander, R. C., Welsh-Bohmer, K. A., Culp, M., Chiang, C., O’Neil, J., Evans, R. M., Harrigan, P., Plassman, B. L., Burke, J. R., et al. (2021) · The Lancet Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 130

Facial emotion recognition performance differentiates between behavioral variant frontotemporal dementia and major depressive disorder

Chiu, I., Piguet, O., Diehl-Schmid, J., Riedl, L., Beck, J., Leyhe, T., Holsboer-Trachsler, E., Kressig, R. W., Berres, M., Monsch, A. U., et al. (2018) · The Journal of Clinical Psychiatry

Dementia and Cognitive Impairment ResearchFace Recognition and Perception

Cited by 31

Smartphone-based continuous mobility monitoring of Parkinsons disease patients reveals impacts of ambulatory bout length on gait features

Cheng, W.-Y., Lipsmeier, F., Scotland, A., Creagh, A., Kilchenmann, T., Jin, L., Schjodt-Eriksen, J., Wolf, D., Zhang-Schaerer, Y.-P., Garcia, I. F., et al. (2017) · 2017 IEEE Life Sciences Conference (LSC)

Balance, Gait, and Falls PreventionContext-Aware Activity Recognition Systems

Cited by 13